Nima Kokabi, MD

Associate Professor of Radiology
University of North Carolina - Chapel Hill, United States

Presentation(s):

• Corporate Lunch Symposium: LOBO & GO: Case Based Learnings On Next-Gen Embolization (Presented by Okami Medical)

  Saturday, April 11, 2026
  12:10 PM - 1:10 PM ET

• Endovascular Management of Peripheral Arterial Hemorrhage Using the Low-Profile Braided Occluder (LOBO®): A Single-Center Experience

  Sunday, April 12, 2026
  3:36 PM - 3:45 PM ET

• Utilization and Safety of Thermal Ablation Compared to Surgical Resection in T1bN0M0 Renal Cell Carcinoma: A Population-based National Cancer Database Analysis

  Sunday, April 12, 2026
  4:03 PM - 4:12 PM ET

• OCCLUDE Final Results: A Prospective, Multicenter, Real-World Study Evaluating the Effectiveness and Safety of Obsidio™ Conformable Embolic in 125 patients

  Sunday, April 12, 2026
  3:36 PM - 3:45 PM ET

• DOORwaY90: Selective Internal Radiation Therapy using SIR-Spheres Y-90 Resin Microspheres as first-line treatment for unresectable Hepatocellular Carcinoma patients (NCT04736121)

  Sunday, April 12, 2026
  3:54 PM - 4:03 PM ET

• Corporate Breakfast Symposium: Rethinking Embolization: Physician Experience with the TriNav™ Infusion System. A Panel discussion led by Nima Kokabi, MD (Presented by TriSalus Life Sciences)

  Monday, April 13, 2026
  7:45 AM - 8:30 AM ET

• Comparative Outcomes of Surgery and Contemporary Interventional Radiology Therapies for Early-Stage Hepatocellular Carcinoma: A National Cancer Database Propensity-Weighted Analysis

  Monday, April 13, 2026
  3:00 PM - 3:09 PM ET

• Safety and Efficacy of the LOBO® Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations (PAVM): A Single-Center Experience

  Tuesday, April 14, 2026
  3:00 PM - 3:09 PM ET

• High-Specific-Activity Resin Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma: A Study of Effectiveness, Safety, and Dosimetry Considerations

  Wednesday, April 15, 2026
  11:51 AM - 12:00 PM ET

• Predictors of Hepatic Decompensation Post-Y90 Treatment in Hepatocellular Carcinoma: New Insights into Segmental TARE and Post-Treatment Dosimetry

  Wednesday, April 15, 2026
  12:00 PM - 12:09 PM ET